AstroNova posts strong Q3 results and margin growth, boosting its stock. ALOT stock trades at low valuation multiples. Read here for more analysis.
Worthing fans have two Christmas crackers to look forward to – and a new year that will be dominated by a promotion challenge.
Bristol-Myers Squibb Company is rated a Buy with solid rebound and robust free cash flow margins. Learn more about BMY stock ...